Position in SANA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$686,591
-$331,725 QoQ
Shares Held
196,731
-44.4% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 211 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. SANA ranks #106 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in SANA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $686,591 | 196,731 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,018,316 | 353,582 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,115,839 | 274,162 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $951,346 | 267,985 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $327,826 | 195,135 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $511,577 | 313,851 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,350,048 | 324,531 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,858,747 | 340,430 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,959,320 | 495,932 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,785,465 | 437,614 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,257,293 | 324,882 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,001,266 | 335,783 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,334,961 | 408,245 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,021,313 | 511,725 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,574,996 | 429,166 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,381,074 | 370,307 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,005,538 | 484,932 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,051,928 | 197,153 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,630,988 | 72,424 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,716,318 | 87,300 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||